Mutsuharu Hayashi.Predictors of in-hospital mortality in elderly patients with heart failure treated with tolvaptan .Fujita medical journal.2023;9 (2).
Hirotaka Sakai. The effect of introducing a nurse-practitioner-led peripherally inserted central venous catheter placement program on the utilization of central venous access device: A retrospective study in Japan. The Journal of Vascular Access. June 21, 2023.
Mutsuharu Hayashi.Impact of heart failure severity on bone mineral density among older patients with heart failure. Heart and vessels,2021; 36(12) 1856-1860.
Mutsuharu Hayashi.Combined Assessment of D-Dimer with the Get with the Guidelines—Heart Failure Risk Score and N-Terminal Pro-B-Type Natriuretic Peptide in Patients with Acute Decompensated Heart Failure with Preserved and Reduced Ejection Fraction.Journal of Clinical Medicine,2021; 10(16) 3564-3564.
Mutsuharu Hayashi.Circulating miR-489 as a potential new biomarker for idiopathic dilated cardiomyopathy. Fujita medical journal ,2021;7(1) 18-22.
Mutsuharu Hayashi.Effect of cardiac rehabilitation on circulating microRNA expression in heart failure: a preliminary study. Fujita medical journal,2021; 7(3) 76-82.
Mutsuharu Hayashi.Impact of physical function on indeterminable anaerobic threshold in patients with heart failure. Fujita medical journal,2021; 7(2) 65-69.
Sakai Hirotaka .External validation of the MPC score for predicting the risk of peripherally inserted central catheter-associated bloodstream infections: A single-center study in Japan. Infection Control & Hospital Epidemiology.
Mutsuharu Hayashi.Predictive impact of early mobilization on rehospitalization for elderly Japanese heart failure patients. Heart and vessels,2020; 35(4) 531-536 .
Mutsuharu Hayashi.Urinary Liver-Type Fatty-Acid-Binding Protein Predicts Long-Term Adverse Outcomes in Medical Cardiac Intensive Care Units. Journal of clinical medicine,2020; 9(2) .
Mutsuharu Hayashi.The difference in determinant factor of six-minute walking distance between sarcopenic and non-sarcopenic elderly patients with heart failure. Journal of cardiology,2020; 75(1) 42-46.
Mutsuharu Hayashi.Serum microRNA-126 and -223 as new-generation biomarkers for sarcoidosis in patients with heart failure.Journal of Cardiology 2018 Dec;72(6):452-457.